COVID-19 Impact on Global Transdermal Patch Drug Delivery System Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Shunt Way
  • 1.4.3 Intercellular Lipid Structure Pathway
  • 1.4.4 Trans-cellular Pathway
• 1.5 Market by Application
  • 1.5.1 Global Transdermal Patch Drug Delivery System Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Home Care
  • 1.5.5 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Patch Drug Delivery System Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Transdermal Patch Drug Delivery System Industry
    • 1.6.1.1 Transdermal Patch Drug Delivery System Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Transdermal Patch Drug Delivery System Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Transdermal Patch Drug Delivery System Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Transdermal Patch Drug Delivery System Market Perspective (2015-2026)
• 2.2 Transdermal Patch Drug Delivery System Growth Trends by Regions
  • 2.2.1 Transdermal Patch Drug Delivery System Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Transdermal Patch Drug Delivery System Historic Market Share by Regions (2015-2020)
  • 2.2.3 Transdermal Patch Drug Delivery System Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Transdermal Patch Drug Delivery System Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Transdermal Patch Drug Delivery System Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Transdermal Patch Drug Delivery System Players by Market Size
  • 3.1.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue (2015-2020)
  • 3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Transdermal Patch Drug Delivery System Market Concentration Ratio
  • 3.2.1 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Transdermal Patch Drug Delivery System Revenue in 2019
• 3.3 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
• 3.4 Key Players Transdermal Patch Drug Delivery System Product Solution and Service
• 3.5 Date of Enter into Transdermal Patch Drug Delivery System Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2015-2020)
• 4.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2021-2026)

5 Transdermal Patch Drug Delivery System Breakdown Data by Application (2015-2026)

• 5.1 Global Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)
• 5.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 6.2 Transdermal Patch Drug Delivery System Key Players in North America (2019-2020)
• 6.3 North America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 6.4 North America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 7.2 Transdermal Patch Drug Delivery System Key Players in Europe (2019-2020)
• 7.3 Europe Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 7.4 Europe Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

8 China

• 8.1 China Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 8.2 Transdermal Patch Drug Delivery System Key Players in China (2019-2020)
• 8.3 China Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 8.4 China Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 9.2 Transdermal Patch Drug Delivery System Key Players in Japan (2019-2020)
• 9.3 Japan Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 9.4 Japan Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 10.2 Transdermal Patch Drug Delivery System Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 10.4 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

11 India

• 11.1 India Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 11.2 Transdermal Patch Drug Delivery System Key Players in India (2019-2020)
• 11.3 India Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 11.4 India Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Transdermal Patch Drug Delivery System Market Size (2015-2020)
• 12.2 Transdermal Patch Drug Delivery System Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020)
• 12.4 Central & South America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Hisamitsu Pharmaceutical
  • 13.1.1 Hisamitsu Pharmaceutical Company Details
  • 13.1.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue
  • 13.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Introduction
  • 13.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020))
  • 13.1.5 Hisamitsu Pharmaceutical Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview and Its Total Revenue
  • 13.2.3 Novartis Transdermal Patch Drug Delivery System Introduction
  • 13.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 ProSolus
  • 13.3.1 ProSolus Company Details
  • 13.3.2 ProSolus Business Overview and Its Total Revenue
  • 13.3.3 ProSolus Transdermal Patch Drug Delivery System Introduction
  • 13.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.3.5 ProSolus Recent Development
• 13.4 Tapemark
  • 13.4.1 Tapemark Company Details
  • 13.4.2 Tapemark Business Overview and Its Total Revenue
  • 13.4.3 Tapemark Transdermal Patch Drug Delivery System Introduction
  • 13.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.4.5 Tapemark Recent Development
• 13.5 Tesa Labtec
  • 13.5.1 Tesa Labtec Company Details
  • 13.5.2 Tesa Labtec Business Overview and Its Total Revenue
  • 13.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Introduction
  • 13.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.5.5 Tesa Labtec Recent Development
• 13.6 NITTO DENKO CORPORATION
  • 13.6.1 NITTO DENKO CORPORATION Company Details
  • 13.6.2 NITTO DENKO CORPORATION Business Overview and Its Total Revenue
  • 13.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Introduction
  • 13.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.6.5 NITTO DENKO CORPORATION Recent Development
• 13.7 Noven Pharmaceuticals
  • 13.7.1 Noven Pharmaceuticals Company Details
  • 13.7.2 Noven Pharmaceuticals Business Overview and Its Total Revenue
  • 13.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Introduction
  • 13.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.7.5 Noven Pharmaceuticals Recent Development
• 13.8 LTS Lohmann Therapie-Systeme
  • 13.8.1 LTS Lohmann Therapie-Systeme Company Details
  • 13.8.2 LTS Lohmann Therapie-Systeme Business Overview and Its Total Revenue
  • 13.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Introduction
  • 13.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.8.5 LTS Lohmann Therapie-Systeme Recent Development
• 13.9 Medherant
  • 13.9.1 Medherant Company Details
  • 13.9.2 Medherant Business Overview and Its Total Revenue
  • 13.9.3 Medherant Transdermal Patch Drug Delivery System Introduction
  • 13.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.9.5 Medherant Recent Development
• 13.10 Corium
  • 13.10.1 Corium Company Details
  • 13.10.2 Corium Business Overview and Its Total Revenue
  • 13.10.3 Corium Transdermal Patch Drug Delivery System Introduction
  • 13.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 13.10.5 Corium Recent Development
• 13.11 Antares Pharma
  • 10.11.1 Antares Pharma Company Details
  • 10.11.2 Antares Pharma Business Overview and Its Total Revenue
  • 10.11.3 Antares Pharma Transdermal Patch Drug Delivery System Introduction
  • 10.11.4 Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.11.5 Antares Pharma Recent Development
• 13.12 Syntropharma
  • 10.12.1 Syntropharma Company Details
  • 10.12.2 Syntropharma Business Overview and Its Total Revenue
  • 10.12.3 Syntropharma Transdermal Patch Drug Delivery System Introduction
  • 10.12.4 Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.12.5 Syntropharma Recent Development
• 13.13 Teikoku Pharma
  • 10.13.1 Teikoku Pharma Company Details
  • 10.13.2 Teikoku Pharma Business Overview and Its Total Revenue
  • 10.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Introduction
  • 10.13.4 Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.13.5 Teikoku Pharma Recent Development
• 13.14 Mylan
  • 10.14.1 Mylan Company Details
  • 10.14.2 Mylan Business Overview and Its Total Revenue
  • 10.14.3 Mylan Transdermal Patch Drug Delivery System Introduction
  • 10.14.4 Mylan Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.14.5 Mylan Recent Development
• 13.15 Actavis
  • 10.15.1 Actavis Company Details
  • 10.15.2 Actavis Business Overview and Its Total Revenue
  • 10.15.3 Actavis Transdermal Patch Drug Delivery System Introduction
  • 10.15.4 Actavis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.15.5 Actavis Recent Development
• 13.16 Mundipharma
  • 10.16.1 Mundipharma Company Details
  • 10.16.2 Mundipharma Business Overview and Its Total Revenue
  • 10.16.3 Mundipharma Transdermal Patch Drug Delivery System Introduction
  • 10.16.4 Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.16.5 Mundipharma Recent Development
• 13.17 Henan Lingrui Pharmaceutical
  • 10.17.1 Henan Lingrui Pharmaceutical Company Details
  • 10.17.2 Henan Lingrui Pharmaceutical Business Overview and Its Total Revenue
  • 10.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Introduction
  • 10.17.4 Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.17.5 Henan Lingrui Pharmaceutical Recent Development
• 13.18 Changzhou Siyao
  • 10.18.1 Changzhou Siyao Company Details
  • 10.18.2 Changzhou Siyao Business Overview and Its Total Revenue
  • 10.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Introduction
  • 10.18.4 Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.18.5 Changzhou Siyao Recent Development
• 13.19 Rfl Pharmaceutical
  • 10.19.1 Rfl Pharmaceutical Company Details
  • 10.19.2 Rfl Pharmaceutical Business Overview and Its Total Revenue
  • 10.19.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Introduction
  • 10.19.4 Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)
  • 10.19.5 Rfl Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer